The present invention relates generally to the field of inflammation. More particularly, the present invention relates to reducing release of pro-inflammatory cytokines induced to MUC1 activity. In one aspect, the present invention provides a method of modulating (inhibiting or promoting) an inflammatory response wherein modulation of the inflammatory response is desired, comprising administering an effective amount of an agent which inhibits or promotes MUC-1 function to an individual.
